Literature DB >> 18291174

Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.

Michele De Bonis1, Elisabetta Lapenna, Alessandro Verzini, Giovanni La Canna, Antonio Grimaldi, Lucia Torracca, Francesco Maisano, Ottavio Alfieri.   

Abstract

BACKGROUND: The aim of this study was to assess the occurrence of reverse left ventricular (LV) remodeling after effective mitral valve repair in advanced dilated cardiomyopathy and its impact on clinical outcome and repair durability.
METHODS: Of 111 patients undergoing mitral valve repair in ischemic or idiopathic dilated cardiomyopathy, 79 patients with no or trivial residual mitral regurgitation (MR) at discharge and with a follow-up length of at least 6 months were included in this study. Preoperatively they had 3 to 4+ functional MR, an ejection fraction of 0.28 +/- 0.055, an indexed LV end-diastolic volume of 113 +/- 33.0 mL/m2, an indexed LV end-systolic volume of 80.8 +/- 26.3 mL/m2, a tenting area of 2.7 +/- 0.9 cm2, and a coaptation depth of 1.1 +/- 0.3 cm. Sixty-three patients (79.8%) were in New York Heart Association class III or IV. A complete, rigid or semirigid undersized ring annuloplasty (with or without "edge-to-edge") was used. Concomitant procedures were coronary artery bypass grafting (49 of 79 patients, 62%), tricuspid valve repair (11 of 79 patients, 13.9%), and ablation of permanent atrial fibrillation (13 of 79 patients, 16.4%).
RESULTS: At a mean follow-up of 2 +/- 1.3 years (median, 1.8 years), LV reverse remodeling was documented in 41 patients (51.8%), whereas in 38 patients (48.1%) LV dimensions remained unchanged or increased compared with preoperative values. The persistence or progression of LV remodeling paralleled the recurrence of MR and worsening of symptoms. Recurrence of MR of 3+ or greater was 0% in the "reverse remodeling" group and 18.4% in the "no reverse remodeling" one (p = 0.008). At 3 years, freedom from recurrence of MR of 2+ or greater was 74% +/- 11.7% and 62% +/- 9.2% (p = 0.004) and New York Heart Association class was 1.5 +/- 0.61 and 2 +/- 0.72 (p < 0.0001), respectively. Predictors of reverse remodeling were ischemic etiology (p = 0.04), concomitant coronary artery bypass grafting (p = 0.02), successful ablation of atrial fibrillation (p = 0.05), and shorter history of congestive heart failure (p = 0.06). The use of the edge-to-edge showed a trend toward favoring reverse remodeling compared with isolated annuloplasty (p = 0.08).
CONCLUSIONS: In patients with functional MR undergoing effective repair, the occurrence of reverse LV remodeling is associated with longer repair durability and a better clinical outcome compared with those with persistence or progression of the remodeling process.

Entities:  

Mesh:

Year:  2008        PMID: 18291174     DOI: 10.1016/j.athoracsur.2007.11.021

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  32 in total

Review 1.  Surgical approach to mitral regurgitation in chronic heart failure: when is it an option?

Authors:  Juan A Crestanello
Journal:  Curr Heart Fail Rep       Date:  2012-03

Review 2.  MitraClip-data analysis of contemporary literature.

Authors:  Florian Deuschl; Niklas Schofer; Edith Lubos; Johannes Schirmer; Lenard Conradi; Hendrik Treede; Hermann Reichenspurner; Stefan Blankenberg; Ulrich Schäfer
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

3.  Valvular disease: Functional mitral regurgitation: should all valves be replaced?

Authors:  Maurizio Taramasso; Francesco Maisano
Journal:  Nat Rev Cardiol       Date:  2016-01-04       Impact factor: 32.419

4.  Mitral valve repair for ischemic mitral regurgitation: lessons from the Cardiothoracic Surgical Trials Network randomized study.

Authors:  Christos G Mihos; Orlando Santana
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

5.  Comparison of mitral competence after mitral repair with papillary muscle approximation versus papillary muscle relocation for functional mitral regurgitation.

Authors:  Koji Furukawa; Mitsuhiro Yano; Eisaku Nakamura; Masakazu Matsuyama; Masanori Nishimura; Katsuya Kawagoe; Kunihide Nakamura
Journal:  Heart Vessels       Date:  2017-08-12       Impact factor: 2.037

6.  The effect of mitral annuloplasty shape in ischemic mitral regurgitation: a finite element simulation.

Authors:  Vincent M Wong; Jonathan F Wenk; Zhihong Zhang; Guangming Cheng; Gabriel Acevedo-Bolton; Mike Burger; David A Saloner; Arthur W Wallace; Julius M Guccione; Mark B Ratcliffe; Liang Ge
Journal:  Ann Thorac Surg       Date:  2012-01-15       Impact factor: 4.330

Review 7.  Percutaneous Mitral Valve Repair with MitraClip: Patient and Valve Selection for Optimal Outcome.

Authors:  Devdas T Inderbitzin; Maurizio Taramasso; Fabian Nietlispach; Francesco Maisano
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

8.  Elimination of ischemic mitral regurgitation does not alter long-term left ventricular remodeling in the ovine model.

Authors:  Kanji Matsuzaki; Masato Morita; Hirotsugu Hamamoto; Mio Noma; J Daniel Robb; Matthew J Gillespie; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

9.  [Mitral regurgitation in heart failure. Surgical therapy].

Authors:  H Aubin; H Kamiya; A Lichtenberg
Journal:  Herz       Date:  2013-03       Impact factor: 1.443

10.  Interventional vs. surgical mitral valve therapy. Which technique for which patient?

Authors:  M Taramasso; N Buzzatti; G La Canna; A Colombo; O Alfieri; F Maisano
Journal:  Herz       Date:  2013-08       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.